Research activities in this department are focused on seeking answers for treatment and management of complex human diseases such as cancer and rare bone marrow failure syndromes and hematological disorders. The department is equipped with state-of-the-art research instruments and highly competent faculty with vast experience in the fields of genetics and cancer. Some of the thrust areas include genomics and epigenetics of rare genetic diseases and cancers, the role of small RNAs and noncoding RNAs in cell signaling pathways, the role of ribosomes in human diseases, nucleolar proteins and their role in tumorigenesis, and stem cell deregulation in cancer. The department also focuses on the discovery and development of small molecule anti-cancer drugs through the whole animal small molecule screening or high throughput screening of chemicals using the zebrafish model system. Recently, zebrafish have emerged as a powerful cancer model system because they develop tumors that are histologically similar to human tumors and many human cancer genes are conserved structurally and functionally in zebrafish. In addition, this fish is amenable to pharmacological testing which makes them useful for screening anti- cancer agents. Apart from fish models, the department also houses mice models, which provide exceptional insights into the biology and genetics of human cancer. They are easy to handle and have disease manifestations consistent with humans. In addition to the research activities, the department is dedicated to educating and training the next generation of cancer investigators and human geneticists. The department has been established with a vision of bringing research scientists and clinicians together in order to effectively translate research findings into new ways to detect and treat cancer and genetic disorders.
My specific area of research is to understand the role of ribosomes in bone marrow failure syndromes and cancer. Other areas of research include developing non-invasive and alternative DNA-based molecular tools for detection of specific mutations in cancer, developing transgenic zebrafish as cancer models and screening of natural antic-cancer compounds in zebrafish using HTS technology.
Selected Publications:
All Publications:
Google Scholar: https://scholar.google.co.in/citations?user=g-vUFywAAAAJ&hl=en
ResearchGate: www.researchgate.net/profile/Anirban_Chakraborty12
Currently enrolled PhD students: 06 Guided PhD students: 02 Guided PG Students: 14
Extramural Funding
Intramural Funding
Over the past 12 years I have worked on development of many new diagnostic techniques for a bacterial, viral pathogen as well as a parasite affecting humans using my expertise on LAMP technique and characterization (identification and function) of cytokines under different stress/infection. At present my research area and interest focusses on development of rapid molecular detection techniques, development of transgenic zebrafish lines for human diseases, Human /animal parasitology, and Molecular Immunology.
Doctor of Philosophy (Applied Biochemistry and Bioscience), University of Miyazaki, Japan, 2007
Master of Science (Aquaculture), West Bengal University of Animal Sciences, Kolkata, 2003
Zebrafish Model system: Transgenesis and disease modelling
Molecular detection techniques
Molecular Genetics
Bioinformatics
Human/animal parasitology
Selected Journal publications (last 5 years)-
PhD : 02 (ongoing); PG: 05 completed and 03 ongoing UG: 06 completed
Undergraduate
Cell based assays in Biomedical Science, Genetic Engineering, Good Laboratory Practices
Postgraduate
Medical Biotechnology, Application Biotechnology in Food Science, Research Ethics & IPR
Extramural Funding
Japan-Asia Youth Exchange program in Science for undergraduates (SAKURA exchange program in science) coordinator, 2018
Japan-Asia Youth Exchange program in Science (SAKURA exchange program in science) awardee, 2016
Dr. Vivek completed his Ph.D. (Molecular & Cell Biology) from Institut de Genetique et de Biologie Moleculaire et Cellulaire (IGBMC), Strasbourg Université, France. He has worked as a DBT research associate at National Institute of Immunology (NII), New Delhi India. He did his post-doc at Erasmus University Medical Center (Erasmus MC), Rotterdam, The Netherlands. His research focus includes replication stress mediated DNA damage response and tumorigenesis. Further, he discovered a molecular mechanism underlying the oscillation between sensitivity and resistance to FDA-approved PARP inhibitor drugs for BRCA1- and BRCA2 mutated breast cancer cells with important implications for treatment strategies and patient outcomes. His research interest includes identifying the novel druggable molecular targets associated with SUMOylation/Ubiquitylation cellular pathways and discovering their potential roles in the modulation of replication fork dynamics and genome stability. Thereafter, determine their anticancer efficacy by employing advanced experimental techniques to develop combined therapies which would involve increasing their sensitivity to existing therapeutic drugs for the treatments of cancer patients in the clinics.
Associate Professor G-I, Nitte University Centre for Science Education and Research (NUCSER) (2023-till date)
• Post-doc, Department of Molecular Genetics, Erasmus University Medical Center (Erasmus MC), Rotterdam, The Netherlands (2018- 2022)
• DBT- Research Associate, Department of Genetics, Cell Signalling & Cancer Biology, National Institute of Immunology (NII), New Delhi, India (2013-2018)
Replication Stress and DNA damage
• Fork Stabilization and Genome Stability
• Molecular Biology & Chemoresistance
Member, Academic Committee, NUCSER
Selected Publications
All Publications:
Google Scholar: https://scholar.google.com/citations?user=tt_F5OgAAAAJ&hl=en
Orcid ID: https://orcid.org/my-orcid?orcid=0000-0002-4453-0105
PhD students: 01 (ongoing), UG students: 02 (completed)
Undergraduate: Clinical Genetics
With more than 15 years of experience in research and teaching, she has attended several conferences and been resource person at National and International level. Her latest visit to the U.S.A where she was invited as speaker to present a research paper on Zika virus at the First International Conference on Zika Virus 2017 held at Washington D.C, 2017. Her major research areas include Parasitology with special interest in Malaria in the city of Mangaluru where drug resistance is beginning to appear. She is presently working in the division of Bioinformatics and Computational genomics with increased surveillance and research on various viruses spreading across the globe.
Assistant Professor, Nitte University Center for Science Education and Research, Mangaluru (2013- till date)
Project Assistant, College of Fisheries, Mangaluru (2006-2013)
Molecular characterization of malarial plasmodium
Malaria and Antimicrobial Resistance
Molecular Biology
Bioinformatics
Sequencing and bioinformatics
Member, Board of Studies in Biological Sciences (UG and PG), Nitte DU
Member, Lab Vigilance Committee, NUCSER
Program Officer-NSS, NUCSER
Life member, Society for Biological Chemists
Journal publications
PhD student :01 (ongoing) • PG student: 03 (completed), 02 ongoing • UG students: 02 (completed), 02 ongoing
PhD student :01 (ongoing)
• PG student: 03 (completed), 02 ongoing
• UG students: 02 (completed), 02 ongoing
Currently guiding Ph.D. student, working on the malaria problem in south-west India